SCHEMBL178224

SCHEMBL178224

O=C(NCc1cccnc1)Nc1ccc(S(=O)(=O)N(F)CC2CCCCC2)cc1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL163834 0.84 NAMPT (0.81) NAMPT
SCHEMBL165146 0.82 NAMPT (1.00) NAMPT
SCHEMBL164937 0.81 NAMPT (1.00) NAMPT
SCHEMBL164698 0.80 NAMPT (1.00) NAMPT
SCHEMBL163603 0.80 NAMPT (1.00) NAMPT
SCHEMBL160345 0.80 NAMPT (1.00) NAMPT
SCHEMBL29635657 0.79 NAMPT (0.81) NAMPT
SCHEMBL167702 0.79 NAMPT (0.81) NAMPT
SCHEMBL165318 0.79 NAMPT (0.98) NAMPT
SCHEMBL161633 0.78 NAMPT (0.78) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611777-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL]AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER Forma TM, LLC. (US) 2013-07-10 EP disclosed
WO-2012031196-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER FORMA THERAPEUTICS, INC. (US) 2012-03-08 WO disclosed